Screener
Novanta NOVT Medical Solutions — Gross Profit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novanta in its filing.
Tagged under the XBRL concept us-gaap:GrossProfit.
The source filing: Novanta’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335404
| Line item | Three Months Ended July 3, 2026 / Automation Enabling Technologies | Three Months Ended July 3, 2026 / Medical Solutions | Three Months Ended July 3, 2026 / Total | Six Months Ended July 3, 2026 / Automation Enabling Technologies | Six Months Ended July 3, 2026 / Medical Solutions | Six Months Ended July 3, 2026 / Total |
|---|---|---|---|---|---|---|
| Revenue | $136,215 | $129,592 | $265,807 | $267,459 | $256,055 | $523,514 |
| Cost of revenue | 63,419 | 76,714 | 130,707 | 148,443 | ||
| Amortization of purchased intangible assets | 1,200 | 2,555 | 2,400 | 5,114 | ||
| Segment gross profit | 71,596 | 50,323 | 121,919 | 134,352 | 102,498 | 236,850 |
| Research and development and engineering | 9,496 | 14,667 | 18,528 | 28,915 | ||
| Selling, general and administrative | 20,784 | 16,585 | 40,673 | 32,891 | ||
| Amortization of purchased intangible assets | 2,704 | 3,711 | 4,823 | 7,366 | ||
| Restructuring, acquisition, and related costs | 2,020 | 1,753 | 2,583 | 2,993 |
Item 1. Financial Statements
FAQ
- What is Novanta's medical solutions — gross profit?
- Novanta (NOVT) reported medical solutions — gross profit of $50.32M in Q2 2026.
- How has Novanta's medical solutions — gross profit changed year-over-year?
- Novanta's medical solutions — gross profit increased by 1.6% year-over-year, from $49.51M to $50.32M.
- What is the long-term trend for Novanta's medical solutions — gross profit?
- Over 4 years (2021 to 2025), Novanta's medical solutions — gross profit has grown at a 18.6% compound annual growth rate (CAGR), from $100.89M to $199.7M.
- What does medical solutions — gross profit mean?
- The residual profit remaining after deducting the direct costs of goods and services sold from the total revenue of the Medical Solutions segment. It measures the core production efficiency and pricing power of the segment before operating expenses are considered.
Ask your AI about Novanta's medical solutions — gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude